|Bid||207.11 x 800|
|Ask||215.00 x 800|
|Day's Range||207.19 - 212.71|
|52 Week Range||187.16 - 372.12|
|Beta (5Y Monthly)||0.44|
|PE Ratio (TTM)||20.74|
|Earnings Date||Apr 20, 2022 - Apr 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||242.00|
Biogen Inc. said in a statement that it stopped a post-marketing clinical trial testing its Alzheimer's disease therapy Aduhelm, citing a Medicare policy that will limit usage of the drug. The company updated the study's ClinicalTrials.gov
Machelle Sanders, secretary of the Department of Commerce for North Carolina, climbed the corporate ranks before taking charge of the state's thriving economic development prospects. Now, she must keep the momentum going.
Armany is a rising junior at Northeastern University majoring in electrical and computer engineering who developed a passion for science during his time as a Biogen Community Lab student and as a R...